Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo.

Autor: de Haan F; Innovation Studies Group, Copernicus Institute, Utrecht University, Utrecht, The Netherlands. fdehaan12@gmail.com., Onyamboko MA; Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo. akatshimarie@yahoo.fr., Fanello CI; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK. caterina@tropmedres.ac.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. caterina@tropmedres.ac., Woodrow CJ; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK. charlie@tropmedres.ac.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. charlie@tropmedres.ac., Lubell Y; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK. yoel@tropmedres.ac.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. yoel@tropmedres.ac., Boon WP; Innovation Studies Group, Copernicus Institute, Utrecht University, Utrecht, The Netherlands. w.p.c.boon@uu.nl., Dondorp AM; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK. arjen@tropmedres.ac.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. arjen@tropmedres.ac.

Publikováno v: Malaria journal [Malar J] 2015 Dec 15; Vol. 14, pp. 503. Date of Electronic Publication: 2015 Dec 15.

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe.

Autor: Ebbers HC; Division of Pharmaceutics, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands. h.ebbers@uu.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands. h.ebbers@uu.nl., Langedijk J; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands.; Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands., Bouvy JC; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands., Hoekman J; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands.; Innovation Studies Group, Faculty of Geosciences, Utrecht University, Utrecht, The Netherlands., Boon WP; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands.; Innovation Studies Group, Faculty of Geosciences, Utrecht University, Utrecht, The Netherlands., de Jong JP; Exon Consultancy, Amsterdam, The Netherlands., De Bruin ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO box 80082, 3508 TB, Utrecht, The Netherlands. M.L.deBruin@uu.nl.; Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands. M.L.deBruin@uu.nl.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2015 Oct; Vol. 71 (10), pp. 1237-44. Date of Electronic Publication: 2015 Jul 25.

Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe.

Autor: Boon WP; Innovation Studies Group, Utrecht University, Utrecht, The Netherlands. w.boon@geo.uu.nl, Moors EH, Meijer A, Schellekens H

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2010 Dec; Vol. 88 (6), pp. 848-53. Date of Electronic Publication: 2010 Oct 20.